Laurus Labs Limited — research summary

Price history, fundamentals, business-quality scores, DCF intrinsic value, shareholding, quarterly results and risk metrics for Laurus Labs Limited, explained in plain English.

• ▪Laurus Labs Limited is tracked in the Pharma & Healthcare sector of our NSE large-cap universe.
• ▪Reported fundamentals show a net margin of 15.04%, debt to equity of 46.37.
• ▪Our transparent MaxGrade checklist scores it B (73/100) across momentum, growth, profitability and safety, using Pharma & Healthcare sector medians as the bar.
• ▪Annualised volatility over the past year is 28.5% with a maximum drawdown of -16.27% and a beta of 0.77 against NIFTY 50.

Figures from the current session. Market open.